These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21711026)

  • 21. Hydrogen-bonded water molecules in the M2 channel of the influenza A virus guide the binding preferences of ammonium-based inhibitors.
    Gianti E; Carnevale V; DeGrado WF; Klein ML; Fiorin G
    J Phys Chem B; 2015 Jan; 119(3):1173-83. PubMed ID: 25353315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
    Leonov H; Astrahan P; Krugliak M; Arkin IT
    J Am Chem Soc; 2011 Jun; 133(25):9903-11. PubMed ID: 21534619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW; Jo WH
    J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel.
    Balannik V; Carnevale V; Fiorin G; Levine BG; Lamb RA; Klein ML; Degrado WF; Pinto LH
    Biochemistry; 2010 Feb; 49(4):696-708. PubMed ID: 20028125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.
    Thomaston JL; Wu Y; Polizzi N; Liu L; Wang J; DeGrado WF
    J Am Chem Soc; 2019 Jul; 141(29):11481-11488. PubMed ID: 31184871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.
    Yu Y; Li X; Hao P; Wang JF; Chou KC
    Curr Drug Metab; 2014; 15(5):526-34. PubMed ID: 24909420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
    Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic membrane association of the cytoplasmic tail of influenza virus M2 protein and lateral membrane sorting regulated by cholesterol binding and palmitoylation.
    Thaa B; Levental I; Herrmann A; Veit M
    Biochem J; 2011 Aug; 437(3):389-97. PubMed ID: 21592088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extension of the free energy workflow FEW towards implicit solvent/implicit membrane MM-PBSA calculations.
    Homeyer N; Gohlke H
    Biochim Biophys Acta; 2015 May; 1850(5):972-982. PubMed ID: 25450172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug inhibition and proton conduction mechanisms of the influenza a M2 proton channel.
    Gu R; Liu LA; Wei D
    Adv Exp Med Biol; 2015; 827():205-26. PubMed ID: 25387967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
    Khurana E; Devane RH; Dal Peraro M; Klein ML
    Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational investigation of drug-resistant mutant of M2 proton channel (S31N) against rimantadine.
    Karthick V; Ramanathan K
    Cell Biochem Biophys; 2014 Nov; 70(2):975-82. PubMed ID: 24807842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
    Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S
    Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
    Rey-Carrizo M; Gazzarrini S; Llabrés S; Frigolé-Vivas M; Juárez-Jiménez J; Font-Bardia M; Naesens L; Moroni A; Luque FJ; Vázquez S
    Eur J Med Chem; 2015; 96():318-29. PubMed ID: 25899336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.
    Wang J; Ma C; Fiorin G; Carnevale V; Wang T; Hu F; Lamb RA; Pinto LH; Hong M; Klein ML; DeGrado WF
    J Am Chem Soc; 2011 Aug; 133(32):12834-41. PubMed ID: 21744829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.